Gurutz Linazasoro, MD, VIVEbiotech, Gipuzkoa, Spain, discusses the manufacturing of lentiviral vectors in supporting the development of ConvertibleCAR-T cell therapy. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).